Showing results (111-120 of 300) with videos related to

Sort By:
Pageof 30
Current Oncology (Toronto, Ont.)|August 25, 2022
Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective StudyFederica Bernardini, Gabriella Ferrandina, Caterina Ricci, et al.
Journal of Minimally Invasive Gynecology|November 19, 2016
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control StudyValerio Gallotta, Carla Cicero, Carmine Conte, et al.
Journal of Minimally Invasive Gynecology|March 20, 2018
Near-Infrared Imaging with Indocyanine Green for Detection of Endometriosis Lesions (Gre-Endo Trial): A Pilot StudyFrancesco Cosentino, Giuseppe Vizzielli, Luigi Carlo Turco, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|June 26, 2015
On the cutting edge of intensity modulated radiotherapy and simultaneous integrated boost (IMRT-SIB): The case of a patient with 8 brain metastasesMarica Ferro, Savino Cilla, Gabriella Macchia, et al.
Gynecologic Oncology|March 20, 2012
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1)Gabriella Macchia, Alessio G Morganti, Francesco Deodato, et al.
Oncotargets and Therapy|August 11, 2017
Volumetric modulated arc therapy for treatment of solid tumors: current insightsGabriella Macchia, Francesco Deodato, Savino Cilla, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2023
The potential role of systemic inflammatory markers in predicting recurrence in early-stage cervical cancerMatteo Bruno, Nicolò Bizzarri, Elena Teodorico, et al.
Oncotarget|December 8, 2017
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancerSimona Leonardi, Marianna Buttarelli, Ilaria De Stefano, et al.
BMC Cancer|December 16, 2014
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter studyGabriella Ferrandina, Giacomo Corrado, Floriana Mascilini, et al.
Breast Cancer (Dove Medical Press)|October 17, 2018
Hypofractionated radiotherapy after conservative surgery may increase low-intermediate grade late fibrosis in breast cancer patientsCinzia Digesù, Francesco Deodato, Gabriella Macchia, et al.
Pageof 30